Brexit warning sounded on EU public health systemThe UK could find its ability to counter the threat of a ‘super-gonorrhoea’ and other infectious diseases hampered Share XBrexit warning sounded on EU public health systemhttps://pharmaphorum.com/news/brexit-health-alliance-eu-ewrs/
Merck & Co plans software application to help tackle C. diff infectionsMerck & Co is working a major US hospital provider on a new software system that could help Share XMerck & Co plans software application to help tackle C. diff infectionshttps://pharmaphorum.com/news/merck-co-software-c-diff-infections/
AZ’s Tagrisso wins new NSCLC first-line approval in EuropeAstraZeneca has widened the licence for its cancer drug Tagrisso (osimertinib) in Europe after regulators gave it the Share XAZ’s Tagrisso wins new NSCLC first-line approval in Europehttps://pharmaphorum.com/news/az-tagrisso-nsclc-egfr-europe/
Top pharmaceutical companies in the world in 2017The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability Share XTop pharmaceutical companies in the world in 2017https://pharmaphorum.com/views-and-analysis/top-pharmaceutical-companies-world-2017/
EMA warns Brexit move will cause higher-than-expected staff lossesEurope’s medicines regulator is expecting higher-than-anticipated staff departures as a result of its Brexit-induced move from London to Share XEMA warns Brexit move will cause higher-than-expected staff losseshttps://pharmaphorum.com/news/ema-brexit-staff-losses-amsterdam/
Amgen faces first Neulasta biosimilar rival as FDA approves Mylan drugAmgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar Share XAmgen faces first Neulasta biosimilar rival as FDA approves Mylan drughttps://pharmaphorum.com/news/amgen-neulasta-biosimilar-fda-mylan-fulphila/
Fourth Humira biosimilar set for EU approvalEuropean regulators have backed a new Humira biosimilar for approval, setting up a four-way race for the blockbuster’s Share XFourth Humira biosimilar set for EU approvalhttps://pharmaphorum.com/news/humira-biosimilar-eu-sandoz-chmp/
GSK collaborates on AI-driven drug design with Cloud PharmaceuticalsGlaxoSmithKline (GSK) is set to apply artificial intelligence (AI) technology to improve its drug discovery efforts through a Share XGSK collaborates on AI-driven drug design with Cloud Pharmaceuticalshttps://pharmaphorum.com/news/gsk-ai-drug-design-cloud-pharmaceuticals/
UCB collaborates with Science 37 on virtual clinical trialsUCB is changing the way it conducts some of its research studies, removing the need for patients to Share XUCB collaborates with Science 37 on virtual clinical trialshttps://pharmaphorum.com/news/ucb-science-37-virtual-clinical-trials/
